Insights

Innovative Drug Platforms PsychoGenics has recently launched eCube, an AI-enabled platform for drug discovery, demonstrating their commitment to adopting cutting-edge technology and offering advanced solutions for pharmaceutical companies seeking to accelerate their R&D processes.

Strong Industry Collaborations Their partnership with Sunovion Pharmaceuticals on Phase 3 clinical trials for antipsychotic treatments highlights opportunities for collaborative projects with other biopharmaceutical firms aiming to develop CNS therapeutics.

Funding & Growth Receiving a $3 million SBIR grant indicates strong validation from government agencies and signals potential for further investment, which can be a compelling selling point for clients looking for innovative and financially supported research partners.

Extensive Model Portfolio PsychoGenics offers highly predictive disease models for serious CNS and orphan disorders, making them an attractive partner for companies needing reliable preclinical data to improve the success rate of clinical trials.

Technological Integration Their use of diverse tech stacks, including machine learning tools like scikit-learn and integrated digital platforms, emphasizes their capability to provide data-driven, technologically advanced research services aligned with industry 4.0 trends.

PsychoGenics Tech Stack

PsychoGenics uses 8 technology products and services including Shopify, Lightbox, Slick, and more. Explore PsychoGenics's tech stack below.

  • Shopify
    E-commerce
  • Lightbox
    Javascript Libraries
  • Slick
    Javascript Libraries
  • scikit-learn
    Machine Learning
  • Java
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • WP Featherlight
    Web Platform Extensions
  • Kadence WP Blocks
    Web Platform Extensions

Media & News

PsychoGenics's Email Address Formats

PsychoGenics uses at least 1 format(s):
PsychoGenics Email FormatsExamplePercentage
First.Last@psychogenics.comJohn.Doe@psychogenics.com
89%
FLast@psychogenics.comJDoe@psychogenics.com
9%
F_Last@psychogenics.comJ_Doe@psychogenics.com
1%
Last@psychogenics.comDoe@psychogenics.com
1%

Frequently Asked Questions

What is PsychoGenics's official website and social media links?

Minus sign iconPlus sign icon
PsychoGenics's official website is psychogenics.com and has social profiles on LinkedInCrunchbase.

What is PsychoGenics's NAICS code?

Minus sign iconPlus sign icon
PsychoGenics's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does PsychoGenics have currently?

Minus sign iconPlus sign icon
As of December 2025, PsychoGenics has approximately 166 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technology Officer: D. B.Chief Financial Officer: A. K.Chief Research Officer (cro): A. G.. Explore PsychoGenics's employee directory with LeadIQ.

What industry does PsychoGenics belong to?

Minus sign iconPlus sign icon
PsychoGenics operates in the Research Services industry.

What technology does PsychoGenics use?

Minus sign iconPlus sign icon
PsychoGenics's tech stack includes ShopifyLightboxSlickscikit-learnJavaX-Content-Type-OptionsWP FeatherlightKadence WP Blocks.

What is PsychoGenics's email format?

Minus sign iconPlus sign icon
PsychoGenics's email format typically follows the pattern of First.Last@psychogenics.com. Find more PsychoGenics email formats with LeadIQ.

How much funding has PsychoGenics raised to date?

Minus sign iconPlus sign icon
As of December 2025, PsychoGenics has raised $3M in funding. The last funding round occurred on Aug 28, 2024 for $3M.

PsychoGenics

Research ServicesNew Jersey, United States51-200 Employees

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development.

We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into the clinic.

With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients.

Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.

Section iconCompany Overview

NAICS Code
5417 - Scientific Research and Development Services
Employees
51-200

Section iconFunding & Financials

  • $3M

    PsychoGenics has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Aug 28, 2024 in the amount of $3M.

  • $50M$100M

    PsychoGenics's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $3M

    PsychoGenics has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Aug 28, 2024 in the amount of $3M.

  • $50M$100M

    PsychoGenics's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.